Year |
Citation |
Score |
2018 |
Richter J, Kumar A, Lipka S, Miladinovic B, Velanovich V. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: a Systematic Review and Network Meta-analysis. Gastroenterology. PMID 29305934 DOI: 10.1053/J.Gastro.2017.12.021 |
0.317 |
|
2017 |
Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Bisphosphonates in multiple myeloma: an updated network meta-analysis. The Cochrane Database of Systematic Reviews. 12: CD003188. PMID 29253322 DOI: 10.1002/14651858.Cd003188.Pub4 |
0.305 |
|
2016 |
Mhaskar R, Miladinovic B, Guterbock TM, Djulbegovic B. When are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board members. Bmj Open. 6: e011150. PMID 27683511 DOI: 10.1136/Bmjopen-2016-011150 |
0.316 |
|
2016 |
Lipka S, Kumar A, Miladinovic B, Richter JE. Systematic review with network meta-analysis: comparative effectiveness of topical steroids vs. PPIs for the treatment of the spectrum of eosinophilic oesophagitis. Alimentary Pharmacology & Therapeutics. 43: 663-73. PMID 26834077 DOI: 10.1111/Apt.13537 |
0.31 |
|
2016 |
Djulbegovic B, Tsalatsanis A, Mhaskar R, Hozo I, Miladinovic B, Tuch H. Improving Hospice Referral: Application of Regret-Based Decision Modeling at End-of-Life Care Blood. 128: 535-535. DOI: 10.1182/Blood.V128.22.535.535 |
0.333 |
|
2015 |
Wyman AM, Rodrigues AA, Hahn L, Greene KA, Bassaly R, Hart S, Miladinovic B, Hoyte L. Estimated Levator Ani Subtended Volume: A Novel Assay for Predicting Surgical Failure after Uterosacral Ligament Suspension. American Journal of Obstetrics and Gynecology. PMID 26596232 DOI: 10.1016/J.Ajog.2015.11.005 |
0.325 |
|
2015 |
Bannister-Tyrrell M, Miladinovic B, Roberts CL, Ford JB. Adjustment for compliance behavior in trials of epidural analgesia in labor using instrumental variable meta-analysis. Journal of Clinical Epidemiology. 68: 525-33. PMID 25592169 DOI: 10.1016/J.Jclinepi.2014.11.005 |
0.351 |
|
2014 |
Miladinovic B, Kumar A, Mhaskar R, Djulbegovic B. Benchmarks for detecting 'breakthroughs' in clinical trials: empirical assessment of the probability of large treatment effects using kernel density estimation. Bmj Open. 4: e005249. PMID 25335959 DOI: 10.1136/Bmjopen-2014-005249 |
0.349 |
|
2014 |
Miladinovic B, Chaimani A, Hozo I, Djulbegovic B. Indirect treatment comparison Stata Journal. 14: 76-86. DOI: 10.1177/1536867X1401400106 |
0.306 |
|
2013 |
Miladinovic B, Mhaskar R, Kumar A, Kim S, Schonwetter R, Djulbegovic B. External validation of a web-based prognostic tool for predicting survival for patients in hospice care. Journal of Palliative Care. 29: 140-6. PMID 24380212 DOI: 10.1177/082585971302900302 |
0.344 |
|
2013 |
Djulbegovic B, Kumar A, Miladinovic B, Reljic T, Galeb S, Mhaskar A, Mhaskar R, Hozo I, Tu D, Stanton HA, Booth CM, Meyer RM. Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. Plos One. 8: e58711. PMID 23555593 DOI: 10.1371/Journal.Pone.0058711 |
0.302 |
|
2013 |
Miladinovic B, Mhaskar R, Hozo I, Kumar A, Mahony H, Djulbegovic B. Optimal information size in trial sequential analysis of time-to-event outcomes reveals potentially inconclusive results because of the risk of random error. Journal of Clinical Epidemiology. 66: 654-9. PMID 23403248 DOI: 10.1016/J.Jclinepi.2012.11.007 |
0.316 |
|
2013 |
Wao H, Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Systematic Reviews. 2: 10. PMID 23379753 DOI: 10.1186/2046-4053-2-10 |
0.374 |
|
2013 |
Miladinovic B, Kumar A, Hozo I, Mahony H, Djulbegovic B. Trial sequential analysis may be insufficient to draw firm conclusions regarding statistically significant treatment differences using observed intervention effects: a case study of meta-analyses of multiple myeloma trials. Contemporary Clinical Trials. 34: 257-61. PMID 23274403 DOI: 10.1016/J.Cct.2012.12.006 |
0.351 |
|
2013 |
Reljic T, Kumar A, Mahoney H, Miladinovic B, Kharfan-Dabaja MA, Mhaskar R, Djulbegovic B. Efficacy Of Novel Agents As Maintenance Therapy For Multiple Myeloma: A Direct and Network Meta-Analysis Blood. 122: 1945-1945. DOI: 10.1182/Blood.V122.21.1945.1945 |
0.361 |
|
2013 |
Miladinovic B, Hozo I, Djulbegovic B. Trial sequential boundaries for cumulative meta-analyses Stata Journal. 13: 77-91. DOI: 10.1177/1536867X1301300106 |
0.318 |
|
2012 |
Miladinovic B, Kumar A, Mhaskar R, Kim S, Schonwetter R, Djulbegovic B. A flexible alternative to the Cox proportional hazards model for assessing the prognostic accuracy of hospice patient survival. Plos One. 7: e47804. PMID 23082220 DOI: 10.1371/Journal.Pone.0047804 |
0.334 |
|
2012 |
Djulbegovic B, Kumar A, Glasziou PP, Perera R, Reljic T, Dent L, Raftery J, Johansen M, Di Tanna GL, Miladinovic B, Soares HP, Vist GE, Chalmers I. New treatments compared to established treatments in randomized trials. The Cochrane Database of Systematic Reviews. 10: MR000024. PMID 23076962 DOI: 10.1002/14651858.Mr000024.Pub3 |
0.363 |
|
2012 |
Mhaskar R, Redzepovic J, Wheatley K, Clark OA, Miladinovic B, Glasmacher A, Kumar A, Djulbegovic B. Bisphosphonates in multiple myeloma: a network meta-analysis. The Cochrane Database of Systematic Reviews. 5: CD003188. PMID 22592688 DOI: 10.1002/14651858.Cd003188.Pub3 |
0.386 |
|
2012 |
Mahony H, Kumar A, Mhaskar R, Miladinovic B, Wheatley K, Djulbegovic B. Maintenance Therapies for Multiple Myeloma (MM): A Direct Meta-Analysis Blood. 120: 4271-4271. DOI: 10.1182/Blood.V120.21.4271.4271 |
0.371 |
|
2012 |
Miladinovic B, Kumar A, Mhaskar R, Mahoney H, Wheatley K, Djulbegovic B. Trial Sequential Analysis in Meta-Analyses of Maintenance Therapies for Multiple Myeloma. Blood. 120: 2975-2975. DOI: 10.1182/Blood.V120.21.2975.2975 |
0.348 |
|
2012 |
Mahony H, Kumar A, Mhaskar R, Miladinovic B, Wheatley K, Djulbegovic B. Maintenance Therapies for Multiple Myeloma (MM): A Network Meta-Analysis Blood. 120: 236-236. DOI: 10.1182/Blood.V120.21.236.236 |
0.367 |
|
2012 |
Miladinovic B, Tsokos CP. Bayesian quantiles of extremes Journal of Statistical Theory and Practice. 6: 566-579. DOI: 10.1080/15598608.2012.698206 |
0.529 |
|
2011 |
Miladinovic B, Kumar A, Hozo I, Djulbegovic B. Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-compliance. Bmc Medical Research Methodology. 11: 55. PMID 21510899 DOI: 10.1186/1471-2288-11-55 |
0.368 |
|
2011 |
Djulbegovic B, Kumar A, Miladinovic B, Mhaskar A, Reljic T, Galeb S, Mhaskar R, Iztok H, Tu D, Stanton H, Booth CM, Meyer RM. Success in Meeting the Primary Endpoint in Phase III Trials: A Comparison of Industry and Cooperative Group Trials Blood. 118: 508-508. DOI: 10.1182/Blood.V118.21.508.508 |
0.362 |
|
2011 |
Mhaskar R, Miladinovic B, Tsalatsanis A, Mbah A, Kumar A, Sehwan K, Schonwetter R, Djulbegovic B. External Validation of Prognostic Models in Terminally Ill Patients, Blood. 118: 4186-4186. DOI: 10.1182/Blood.V118.21.4186.4186 |
0.606 |
|
2010 |
Reljic T, Bhansali N, Komrokji RS, Lin K, List AF, Djulbegovic B, Fenstermacher DA, Lancet JE, Miladinovic B, Kumar A. Comparative Effectiveness of Azacitidine Versus Decitabine for the Treatment of Myelodysplastic Syndromes Blood. 116: 3995-3995. DOI: 10.1182/Blood.V116.21.3995.3995 |
0.378 |
|
2010 |
Mhaskar R, Redzepovic J, Wheatley K, Clark O, Glasmacher A, Miladinovic B, Kumar A, Djulbegovic B. Comparative Effectiveness of Bisphoshonates In Multiple Myeloma Blood. 116: 3028-3028. DOI: 10.1182/Blood.V116.21.3028.3028 |
0.355 |
|
2010 |
Mhaskar R, Wao H, Kumar A, Miladinovic B, Djulbegovic B. Role of Iron Supplementation to Erythropoiesis Stimulating Agents In the Management of Chemotherapy-Induced Anemia In Cancer Patients: A Systematic Review and Meta-Analysis Blood. 116: 2055-2055. DOI: 10.1182/Blood.V116.21.2055.2055 |
0.317 |
|
2009 |
Miladinovic B, Tsokos CP. Sensitivity of the bayesian reliability estimates for the modified gumbel failure model International Journal of Reliability, Quality and Safety Engineering. 16: 331-341. DOI: 10.1142/S0218539309003423 |
0.539 |
|
2009 |
Miladinovic B, Tsokos CP. Ordinary, Bayes, empirical Bayes, and non-parametric reliability analysis for the modified Gumbel failure model Nonlinear Analysis, Theory, Methods and Applications. 71: e1426-e1436. DOI: 10.1016/J.Na.2009.01.181 |
0.528 |
|
2008 |
Tsokos CP, Miladinovic B. Bayesian reliability analysis for the Gumbel failure model Neural, Parallel and Scientific Computations. 16: 93-104. |
0.493 |
|
Show low-probability matches. |